Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mackenzie Mills

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Pharmacoeconomics|February 23, 2023
HTA Barriers for Conditional Approval DrugsMackenzie Mills
Health Policy (Amsterdam, Netherlands)|September 1, 2022
How do HTA agencies perceive conditional approval of medicines? Evidence from England, Scotland, France and CanadaMackenzie Mills, Panos Kanavos
Pharmacoeconomics - Open|March 23, 2023
Healthcare Payer Perspectives on the Assessment and Pricing of Oncology Multi-Indication Products: Evidence from Nine OECD CountriesMackenzie Mills, Panos Kanavos
Health Policy (Amsterdam, Netherlands)|January 14, 2020
Do pharmaceutical budgets deliver financial sustainability in healthcare? Evidence from EuropeMackenzie Mills, Panos Kanavos
Hearing Research|July 14, 2018
Perception of noise-vocoded tone complexes: A time domain analysis based on an auditory filterbank modelWilliam P Shofner, Hayley Morris, Mackenzie Mills
Applied Health Economics and Health Policy|July 13, 2022
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and ScotlandDaniel Tobias Michaeli, Mackenzie Mills, Panos Kanavos
BMC Health Services Research|February 14, 2023
Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countriesMackenzie Mills, Daniel Michaeli, Aurelio Miracolo, et al.
Health Policy and Planning|April 22, 2021
Sin taxes and their effect on consumption, revenue generation and health improvement: a systematic literature review in Latin AmericaAurelio Miracolo, Marisa Sophiea, Mackenzie Mills, et al.
Investigational New Drugs|April 7, 2022
Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGADaniel Tobias Michaeli, Mackenzie Mills, Thomas Michaeli, et al.
The Journal of Allergy and Clinical Immunology|May 1, 1983
Antibodies to purified bee venom proteins and peptides. I. Development of a highly specific RAST for bee venom antigens and its application to bee sting allergyD M Kemeny, M G Harries, L J Youlten, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pharmacoeconomics|February 23, 2023
HTA Barriers for Conditional Approval DrugsMackenzie Mills
Health Policy (Amsterdam, Netherlands)|September 1, 2022
How do HTA agencies perceive conditional approval of medicines? Evidence from England, Scotland, France and CanadaMackenzie Mills, Panos Kanavos
Pharmacoeconomics - Open|March 23, 2023
Healthcare Payer Perspectives on the Assessment and Pricing of Oncology Multi-Indication Products: Evidence from Nine OECD CountriesMackenzie Mills, Panos Kanavos
Health Policy (Amsterdam, Netherlands)|January 14, 2020
Do pharmaceutical budgets deliver financial sustainability in healthcare? Evidence from EuropeMackenzie Mills, Panos Kanavos
Hearing Research|July 14, 2018
Perception of noise-vocoded tone complexes: A time domain analysis based on an auditory filterbank modelWilliam P Shofner, Hayley Morris, Mackenzie Mills
Applied Health Economics and Health Policy|July 13, 2022
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and ScotlandDaniel Tobias Michaeli, Mackenzie Mills, Panos Kanavos
BMC Health Services Research|February 14, 2023
Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countriesMackenzie Mills, Daniel Michaeli, Aurelio Miracolo, et al.
Health Policy and Planning|April 22, 2021
Sin taxes and their effect on consumption, revenue generation and health improvement: a systematic literature review in Latin AmericaAurelio Miracolo, Marisa Sophiea, Mackenzie Mills, et al.
Investigational New Drugs|April 7, 2022
Initial and supplementary indication approval of new targeted cancer drugs by the FDA, EMA, Health Canada, and TGADaniel Tobias Michaeli, Mackenzie Mills, Thomas Michaeli, et al.
The Journal of Allergy and Clinical Immunology|May 1, 1983
Antibodies to purified bee venom proteins and peptides. I. Development of a highly specific RAST for bee venom antigens and its application to bee sting allergyD M Kemeny, M G Harries, L J Youlten, et al.
Pageof 2